LMG Life Sciences Awards EMEA 2023 shortlist revealed

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

LMG Life Sciences Awards EMEA 2023 shortlist revealed

LMG-LS-2023-EMEA-logo-article

The LMG Life Sciences Awards is excited to announce its shortlist for the 2023 EMEA Awards.

The LMG Life Sciences Awards has released the full list of finalists for the 2023 EMEA awards.

The awards bring together Europe’s legal community to recognise the leading law firms and lawyers from across the region to celebrate their success in the Life Sciences industry.

Winners will be announced at the black-tie gala celebration which will be held on 13 July 2023 at the Waldorf Hilton.

A preview of the finalists can be found below and the full list of the finalists for all categories is available on the LMG Life Sciences website. The LMG Life Sciences Awards research team carefully selected each finalist after a thorough research period which included an analysis of direct submissions, client feedback, and much deliberation.

Individual practitioners and Rising Stars are judged not only on the complexity of the work the nominees completed in 2022, but also on their advocacy, influence, and thought leadership.

All of the work accepted for shortlisting closed during the research period, which was from January 1 to December 31 2022. The awards do not recognise cases, deals, or transactions completed outside of the research period.

If you have any questions regarding our research process, please contact our editor John Harrison

The LMG Life Sciences Awards will be announcing the winners on July 13 at a live awards gala. To find out more – and to find out about how you can promote your success – please contact Prin Shasiharan.

Preview of the LMG Life Sciences Awards EMEA 2023 shortlist:

  • Patent Litigation Firm of the Year: Biologics & Biosimilars

    Allen & Overy
    Carpmaels & Ransford
    DORDA
    Herbert Smith Freehills
    Pestalozzi Attorneys at Law
    Powell Gilbert
    Taylor Wessing
  • Patent Strategy & Management Firm of the Year

    Bird & Bird
    Deris Attorney at Law Partnership
    Dimitrov Petrov & Co
    Greenberg Traurig
    Kiortsis & Associates
    NSN Law Firm
    The Luzzatto Group
  • Patent Litigator of the Year: Biologics & Biosimilars

    Andreas Seling
    DORDA
    Andri Hess
    Homburger
    David Wilson
    Carpmaels & Ransford
    Emre Kerim Yardimci
    Deris Attorney at Law Partnership
    Laura Orlando
    Herbert Smith Freehills
    Patricia Cappuyns
    Taylor Wessing
    Zoe Butler
    Powell Gilbert

LMG Life Sciences is a sister publication to Managing IP, and is run independently from IP Stars research.



more from across site and SHARED ros bottom lb

More from across our site

News of EasyGroup failing in its trademark infringement claim against ‘Easihire’ and Amgen winning a key appeal at the UPC were also among the top talking points
Submit your nominations to this year's WIBL EMEA Awards by February 16 2026
Edward Russavage and Maria Crusey at Wolf Greenfield say that OpenAI MDL could broaden discovery and reshape how clients navigate AI copyright disputes
The UPC has increased some fees by as much as 32%, but firms and their clients had been getting a good deal so far
Meryl Koh, equity director and litigator at Drew & Napier in Singapore, discusses an uptick in cross-border litigation and why collaboration across practice areas is becoming crucial
The firm says new role will be at the forefront of how it delivers value and will help bridge the gap between lawyers, clients and tech
Qantm IP’s CEO and AI programme lead discuss the business’s investment and M&A plans, and reveal their tech ambitions
Controversial plans were scrapped by the Commission earlier this year after the Parliament had previously backed them
Lawyers at Spoor & Fisher provide an overview of how South Africa is navigating copyright and consent requirements to improve access to works for blind and visually impaired people
Gillian Tan explains how she balances TM portfolio management with fast-moving deals, and why ‘CCP’ is a good acronym to live by
Gift this article